Setmelanotide
Imcivree · RM-493
A melanocortin-4 receptor agonist approved for chronic weight management in specific genetic causes of obesity, including POMC, PCSK1 and LEPR deficiency and Bardet-Biedl syndrome. It acts on an appetite pathway distinct from the GLP-1 receptor.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
~11 h, subcutaneous. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied as a solution in a multiple-dose vial; refrigerated and protected from light per its label.
References
- FDA label: Imcivree (NDA 213793)
Read the source
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.